Výsledky vyhledávání

NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens

Autor: H T Cuypers, A. E. G. K. Von Dem Borne, N. M. Faber, Willem H. Ouwehand, R. W. A. M. Kuijpers

Publikováno v: Journal of Clinical Investigation. 89:381-384

The glycoprotein (GP) Ib/IX complex, a prominent platelet GP complex, is the primary receptor for vWF. Previously, we have established that an antigenic polymorphism of platelets, the HPA-2 or Ko alloantigen system, is located on the 45-kD amino-term

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::859cfd786ec4b9f48cb2f56c91a45d93
https://doi.org/10.1172/jci115596

Zobrazit plný text záznamu

Hepatitis G virus RNA and hepatitis G virus-E2 antibodies in Dutch hemophilia patients in relation to transfusion history

Autor: E P, Mauser-Bunschoten, M, Damen, H L, Zaaijer, M, Sjerps, G, Roosendaal, P N, Lelie, H T, Cuypers, H M, van den Berg

Publikováno v: Blood. 92(6)

The prevalence of hepatitis G virus (HGV)-RNA and HGV-E2 antibodies was studied in a cohort of Dutch hemophilia patients in relation to clotting products used, age, and coinfection with hepatitis C. Between 1991 and 1995, blood samples were taken fro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::54530d3352cc2f2e62a66148d6ded0e1
https://pubmed.ncbi.nlm.nih.gov/9731076

Zobrazit plný text záznamu

[Prevalence of human T-cell lymphotropic virus type I among Dutch blood donors]

Autor: H L, Zaaijer, C, Dudok de Wit, H T, Cuypers, I N, Winkel, P N, Lelie

Publikováno v: Nederlands tijdschrift voor geneeskunde. 137(49)

OBJECTIVE. To establish the prevalence of human T-lymphotropic virus (HTLV) type I among Dutch blood donors. DESIGN. Study to confirm screening results. SETTING. Central Laboratory of the Blood Transfusion Service of the Dutch Red Cross, section Viru

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1fc583c6ac976254cb32b019d61b80b5
https://pubmed.ncbi.nlm.nih.gov/8272141

Zobrazit plný text záznamu

Testing for HCV markers

Autor: H W, Reesink, C L, van der Poel, D, Bresters, H T, Cuypers, H, Zaaijer, P N, Lelie

Publikováno v: Developments in biological standardization. 81

Until 1988 the putative agent of non-A/non-B (NANB) hepatitis had not been found. Research workers of the Chiron Corporation (California, USA) then identified, by "blind expression cloning", polypeptides which specifically bound antibodies present in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ae6be3f4c62de361a6bb6680ee1c22ed
https://pubmed.ncbi.nlm.nih.gov/7513661

Zobrazit plný text záznamu

HCV and blood transfusion

Autor: H W, Reesink, C L, van der Poel, H T, Cuypers, P N, Lelie

Publikováno v: Archives of virology. Supplementum. 4

Posttransfusion hepatitis remains a threat to transfusion therapy. Testing for increased ALT levels has been used in an attempt to reduce this risk. Presence of the infectious agent, hepatitis C virus (HCV), appears to be a much more sensitive criter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d39d62116676aacb0fe4ae30ebaef44e
https://pubmed.ncbi.nlm.nih.gov/1280507

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání